TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.

BACKGROUND Various studies all around the world depicted the relationship of polymorphisms in tumor suppressor genes with risk of various cancers, but there are unambiguous conclusions on this association. A hospital based case-control study was designed to review the association of polymorphism of tumor suppressor genes p21 and p53 with breast cancer risk in women residing in rural Maharashtra. METHODS Two single nucleotide polymorphisms (SNPs) a C>A transversion (Ser>Arg) at codon 31 of exon 2 (rs1801270), C>T transition occurring 20bp upstream from stop codon of exon 3 (rs1059234) in p21 gene and G>C (Arg>Pro) transition at codon 72 of exon 4 (rs1042522), G>T (Arg>Ser) transition at codon 249 in exon 7 (rs28934571) in p53 gene were studied. To precise the quantitative assessment, we enrolled 800 subjects sorted into 400 clinically confirmed breast cancer patients and 400 healthy women from a tertiary care hospital (Krishna Hospital and Medical Research Centre) of south-western Maharashtra. The genetic polymorphisms in p21 and p53 genes was studied by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method using blood genomic DNA isolated from breast cancer patients and controls.  The level of association of polymorphisms was assessed using Odds ratio (OR) with 95% confidence interval and p-value identified using logistic regression model. RESULTS After the analysis of SNPs (rs1801270, rs1059234) of p21 and (rs1042522, rs28934571) in p53 gene our analysis suggested that heterozygote Ser/Arg genotype with OR=0.66; 95% CI: 0.47- 0.91; p=0.0003 and homozygote variant Arg/Arg genotype with OR=0.23; 95% CI: 0.13- 0.40; p<0.0001of rs1801270 of p21 was negatively associated with risk of breast cancer in studied population. CONCLUSION The findings from this study supported that rs1801270 SNP of p21 was inversely associated with breast cancer risk in the studied rural women population.

[1]  G. S. Ali,et al.  Mechanism of Action p53 , 2023, Asian Pacific Journal of Cancer Biology.

[2]  Q. Zhang,et al.  Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review , 2022, Frontiers in Oncology.

[3]  Lin-sen Zhao,et al.  Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis , 2022, Frontiers in Genetics.

[4]  N. Jana,et al.  Gene Regulation by p53 in Human Cancer System , 2022, Asian Pacific Journal of Cancer Biology.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  M. Khan,et al.  Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients , 2020, PloS one.

[7]  L. Hou,et al.  p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies , 2020, BMC medical genetics.

[8]  E. Bowman,et al.  Relationship between the TP53 SNP rs1800371 and Lung Cancer in African Americans , 2019 .

[9]  P. Patra,et al.  Association of TP53 gene codon 72 polymorphism with incidence of cervical cancer in Chhattisgarh , 2019 .

[10]  Maheshwari Patel,et al.  Study , 2019, Definitions.

[11]  H. Salehiniya,et al.  Epidemiological characteristics of and risk factors for breast cancer in the world , 2019, Breast cancer.

[12]  Z. Shao,et al.  Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis , 2019, Bioscience reports.

[13]  R. Mariani-Costantini,et al.  Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors , 2019, Breast Cancer Research and Treatment.

[14]  Z. Qin,et al.  TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status , 2018, Journal of Cancer.

[15]  Xian-Tao Zeng,et al.  Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer , 2018, Front. Physiol..

[16]  S. Nadifi,et al.  The 72Pro Variant of the Tumor Protein 53 Is Associated with an Increased Breast Cancer Risk in the Moroccan Population , 2018, Pathobiology.

[17]  S. Husain,et al.  Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population , 2017, Current genomics.

[18]  Y. Bakri,et al.  Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population , 2017, Pathobiology.

[19]  Song Fan,et al.  Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis , 2017, Chronic diseases and translational medicine.

[20]  S. Merajver,et al.  Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. , 2016, Seminars in oncology.

[21]  S. A. Nair,et al.  Polymorphism of p53 in cancer prognosis , 2016, The Indian journal of medical research.

[22]  S. Kannan,et al.  Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India , 2016, The Indian journal of medical research.

[23]  K. Torres-Poveda,et al.  Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence , 2016, PloS one.

[24]  D. Dobrota,et al.  Association of p53 and p21 polymorphisms with prostate cancer. , 2015, Biomedical reports.

[25]  B. Saikia,et al.  Association of a p53 codon 72 gene polymorphism with environmental factors and risk of lung cancer: a case control study in Mizoram and Manipur, a high incidence region in North East India. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[26]  Sarika Sharma,et al.  TP53 polymorphisms in sporadic North Indian breast cancer patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[27]  R. Mandal,et al.  No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis , 2014, Tumor Biology.

[28]  R. Mandal,et al.  Evaluating the Association between p53 Codon 72 Arg>Pro Polymorphism and Risk of Ovary Cancer: A Meta-Analysis , 2014, PloS one.

[29]  N. Sareen,et al.  Reproductive factors and breast cancer: a case-control study in tertiary care hospital of North India. , 2013, Indian journal of cancer.

[30]  Shuting Jia,et al.  p53 codon 72 polymorphism and breast cancer risk: A meta-analysis , 2013, Experimental and therapeutic medicine.

[31]  Anjaneyulu,et al.  P53 Codon 72 Gene Polymorphism and Risk of Oral Squamous Cell Carcinoma in South Indian Population: A Case-Control Study , 2012 .

[32]  Pravin Murugesan,et al.  p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[33]  M. Shin,et al.  p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population , 2011, Gastric Cancer.

[34]  A. Collins,et al.  The Application of Clinical Genetics Dovepress the Genetics of Breast Cancer: Risk Factors for Disease , 2022 .

[35]  Meshram,et al.  Reproductive Risk Factors for Breast Cancer: A Case Control Study , 2009 .

[36]  F. Tsai,et al.  Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. , 2007, Anticancer research.

[37]  P. Chinnery,et al.  A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians , 2005, BMC ophthalmology.

[38]  T. Eisen,et al.  TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. , 2003, Mutagenesis.

[39]  K. Datkhile,et al.  Role of p53 and p21 Polymorphisms in Cervical Cancer Risk among Rural Population of South-Western Maharashtra: A Case-Control Study , 2019, Indian Journal of Public Health Research & Development.

[40]  B. Saikia,et al.  Association of a p 53 Codon 72 Gene Polymorphism with Environmental Factors and Risk of Lung Cancer : a Case Control Study in Mizoram and Manipur , a High Incidence Region in North East India , 2015 .

[41]  K. Sailaja,et al.  Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[42]  R. Venkatesan,et al.  Association of Trp53 arg72pro polymorphic variants with breast cancer - a case control study in south Indian population , 2011 .